U.S. Markets close in 6 hrs 15 mins

Laboratorios Farmaceuticos ROVI, S.A. (ROVI.MC)

MCE - MCE Delayed Price. Currency in EUR
Add to watchlist
15.72-0.28 (0.00%)
As of 5:35PM CEST. Market open.
Full screen
Previous Close16.00
Open15.72
Bid15.76 x 8400
Ask16.08 x 15000
Day's Range15.72 - 15.72
52 Week Range10.80 - 18.75
Volume13
Avg. Volume3,470
Market Cap775.26M
BetaN/A
PE Ratio (TTM)32.48
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Laboratorios Farmaceúticos Rovi SA : Overvalued relative to peers, but may deserve another look
    Capital Cube5 months ago

    Laboratorios Farmaceúticos Rovi SA : Overvalued relative to peers, but may deserve another look

    Categories: Yahoo FinanceLaboratorios Farmaceúticos Rovi SA relative valuation is now OVERVALUED. It was previously rated UNDERVALUED, and has a fundamental analysis score of 78. Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT). Relative ... Read more (Read more...)

  • Laboratorios Farmaceúticos Rovi SA : A good buy now? Relative to peers, maybe.
    Capital Cube7 months ago

    Laboratorios Farmaceúticos Rovi SA : A good buy now? Relative to peers, maybe.

    Categories: Yahoo Finance Laboratorios Farmaceúticos Rovi SA relative valuation is now UNDERVALUED. It was previously rated OVERVALUED, and has a fundamental analysis score of 72. Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT). Relative ... Read more (Read more...)

  • Laboratorios Farmaceúticos Rovi SA : Fairly valued, but don’t skip the other factors
    Capital Cubelast year

    Laboratorios Farmaceúticos Rovi SA : Fairly valued, but don’t skip the other factors

    Categories: Yahoo Finance Laboratorios Farmaceúticos Rovi SA relative valuation is now NEUTRAL. It was previously rated OVERVALUED, and has a fundamental analysis score of 50. Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT). Relative ... Read more (Read more...)